|
57
|
257
|
1qbvH |
Crystal structure of thrombin complexed with an guanidine-mimetic inhibitor |
|
55
|
259
|
1ppbH |
The refined 1.9 angstroms crystal structure of human alpha-thrombin: interaction with d-phe-pro-arg chloromethylketone and significance of the tyr-pro-pro-trp insertion segment |
|
2
|
36
|
1ppbL |
The refined 1.9 angstroms crystal structure of human alpha-thrombin: interaction with d-phe-pro-arg chloromethylketone and significance of the tyr-pro-pro-trp insertion segment |
|
2
|
27
|
1oytL |
Complex of recombinant human thrombin with a designed fluorinated inhibitor |
|
7
|
29
|
1p8vB |
Crystal structure of the complex of platelet receptor gpib-alpha and alpha-thrombin at 2.6a |
|
58
|
257
|
1oytH |
Complex of recombinant human thrombin with a designed fluorinated inhibitor |
|
63
|
258
|
1p8vC |
Crystal structure of the complex of platelet receptor gpib-alpha and alpha-thrombin at 2.6a |
|
3
|
36
|
1ookA |
Crystal structure of the complex of platelet receptor gpib-alpha and human alpha-thrombin |
|
3
|
33
|
1o5gL |
Dissecting and designing inhibitor selectivity determinants at the s1 site using an artificial ala190 protease (ala190 upa) |
|
57
|
257
|
1o5gH |
Dissecting and designing inhibitor selectivity determinants at the s1 site using an artificial ala190 protease (ala190 upa) |
|
55
|
259
|
1ookB |
Crystal structure of the complex of platelet receptor gpib-alpha and human alpha-thrombin |
|
2
|
36
|
1o2gL |
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors |
|
55
|
259
|
1o2gH |
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors |
|
58
|
259
|
1ny22 |
Human alpha thrombin inhibited by rppgf and hirugen |
|
2
|
23
|
1nrqL |
Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes |
|
40
|
250
|
1nrqH |
Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes |
|
3
|
34
|
1o0dL |
Human thrombin complexed with a d-phe-pro-arg-type inhibitor and a c-terminal hirudin derived exo-site inhibitor |
|
3
|
28
|
1nu7A |
Staphylocoagulase-thrombin complex |
|
2
|
29
|
1nrpL |
Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes |
|
55
|
258
|
1nrsH |
Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes |
|
34
|
146
|
1nl2A |
Bovine prothrombin fragment 1 in complex with calcium and lysophosphotidylserine |
|
63
|
287
|
1nt1A |
Thrombin in complex with selective macrocyclic inhibitor |
|
47
|
254
|
1nrnH |
Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes |
|
64
|
287
|
1nm6A |
Thrombin in complex with selective macrocyclic inhibitor at 1.8a |
|
56
|
257
|
1o0dH |
Human thrombin complexed with a d-phe-pro-arg-type inhibitor and a c-terminal hirudin derived exo-site inhibitor |
|
56
|
258
|
1nu7B |
Staphylocoagulase-thrombin complex |
|
58
|
259
|
1no9H |
Design of weakly basic thrombin inhibitors incorporating novel p1 binding functions: molecular and x-ray crystallographic studies. |
|
1
|
28
|
1nzqL |
D-phe-pro-arg-type thrombin inhibitor |
|
2
|
27
|
1nrsL |
Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes |
|
36
|
147
|
1nl1A |
Bovine prothrombin fragment 1 in complex with calcium ion |
|
2
|
29
|
1nrnL |
Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes |
|
55
|
257
|
1nrrH |
Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes |
|
3
|
36
|
1no9L |
Design of weakly basic thrombin inhibitors incorporating novel p1 binding functions: molecular and x-ray crystallographic studies. |
|
58
|
257
|
1nzqH |
D-phe-pro-arg-type thrombin inhibitor |
|
66
|
290
|
1nu9A |
Staphylocoagulase-prethrombin-2 complex |
|
3
|
26
|
1nrrL |
Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes |
|
3
|
36
|
1ny21 |
Human alpha thrombin inhibited by rppgf and hirugen |
|
35
|
259
|
1nroH |
Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes |
|
2
|
29
|
1nroL |
Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes |
|
42
|
258
|
1nrpH |
Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes |
|
59
|
258
|
1mu6B |
Crystal structure of thrombin in complex with l-378,622 |
|
3
|
26
|
1mu6A |
Crystal structure of thrombin in complex with l-378,622 |
|
3
|
29
|
1mkxL |
The co-crystal structure of unliganded bovine alpha-thrombin and prethrombin-2: movement of the yppw segment and active site residues upon ligand binding |
|
3
|
26
|
1mueA |
Thrombin-hirugen-l405,426 |
|
51
|
255
|
1mkxH |
The co-crystal structure of unliganded bovine alpha-thrombin and prethrombin-2: movement of the yppw segment and active site residues upon ligand binding |
|
60
|
258
|
1mu8B |
Thrombin-hirugen_l-378,650 |
|
3
|
26
|
1mu8A |
Thrombin-hirugen_l-378,650 |
|
59
|
287
|
1mkxK |
The co-crystal structure of unliganded bovine alpha-thrombin and prethrombin-2: movement of the yppw segment and active site residues upon ligand binding |
|
63
|
287
|
1mh0A |
Crystal structure of the anticoagulant slow form of thrombin |
|
58
|
287
|
1mkwK |
The co-crystal structure of unliganded bovine alpha-thrombin and prethrombin-2: movement of the yppw segment and active site residues upon ligand binding |
